肿瘤学杂志
研究文章

转换手术治疗晚期胃癌患者腹膜癌扩散

表1

患者的临床特征。
变量 少量的酒 CRS + HIPEC C / T 缓和
(n= 34) (n= 15) (n= 23) (n= 23)
年龄(y / o) 65.3 (6.02) 66.07 (10.19) 65.91 (11.11) 67.43 (9.05) 0.850
性别(男性) 17 (51.52%) 8 (57.14%) 16 (69.57%) 15 (65.22%) 0.536
伴随疾病 HTN 7 (21.21%) 6 (42.86%) 10 (43.48%) 12 (52.17%) 0.095
计算机辅助设计 3 (9.09%) 3 (21.43%) 5 (21.74%) 8 (34.78%) 0.132
糖尿病 1 (3.03%) 3 (21.43%) 6 (26.09%) 5 (21.74%)
脑血管意外 1 (3.03%) 1 (7.14%) 2 (8.7%) 1 (4.35%) 0.751
ESRD 0 (0%) 0 (0%) 1 (4.35%) 3 (13.04%) 0.077
肺 2 (6.06%) 1 (7.14%) 2 (8.7%) 1 (4.35%) 0.999
(PS) ECOG 0 (%) 10 (30.3%) 4 (28.57%) 11 (47.83%) 10 (43.48%) 0.425
1∼2 (%) 21 (63.64%) 9 (64.29%) 12 (52.17%) 10 (43.48%)
> 3 (%) 2 (6.06%) 1 (7.14%) 0 (0%) 3 (13.04%)
血管 1.48±0.97 1.21±0.43 1.7±1.11 2.09±1.38
TNM阶段 T2 (%) 2 (6.06%) 0 (0%) 3 (13.04%) 6 (26.09%)
T3 (%) 9 (27.27%) 1 (7.14%) 12 (52.17%) 10 (43.48%)
T4 (%) 22 (66.67%) 13 (92.86%) 8 (34.78%) 7 (30.43%)
N1 (%) 3 (9.09%) 1 (7.14%) 6 (26.09%) 7 (30.43%)
N2 (%) 17 (51.52%) 6 (42.86%) 3 (13.04%) 7 (30.43%)
N3 (%) 7 (21.21%) 7 (50%) 11 (47.83%) 9 (39.13%)
症状 腹水(%) 20 (60.61%) 2 (14.29%) 6 (26.09%) 6 (26.09%)
上腹部疼痛(%) 33 (100%) 13 (92.86%) 22 (95.65%) 20 (86.96%) 0.128
UGI出血(%) 11 (33.33%) 4 (28.57%) 7 (30.43%) 10 (43.48%) 0.746
胃出口梗阻(%) 7 (21.21%) 10 (71.43%) 8 (34.78%) 8 (34.78%)
BW损失(%) 18 (54.55%) 3 (21.43%) 13 (56.52%) 15 (65.22%) 0.068
实验室测试 白细胞(m /毫米3) 7080.91±2516.55 7208.57±3637.68 8513.48±2849.05 9082.61±4607.45 0.117
血红蛋白(g / dL) 10.94±2.87 10.37±2.66 10.95±2.76 10.22±2.74 0.728
钠(毫克当量/ L) 137.12±3.62 137.43±3.11 135.57±3.92 137.13±2.44 0.260
钾(更易/ L) 3.67±0.42 3.94±0.41 3.82±0.45 3.87±0.48 0.193
AST (U / L) 19.42±9.86 21.64±10.3 41.74±75.95 56.7±94.08 0.154
Cr (mg / dL) 0.75±0.22 0.88±0.18 1.07±0.65 1.07±0.64
白蛋白(g / dL) 3.38±0.56 3.46±0.36 3.24±0.48 3.06±0.64 0.083
HTN、高血压;CAD、冠状动脉疾病;脑血管意外、脑血管意外;终末期肾病(ESRD;PS (ECOG):病人性能(东部合作肿瘤组);血管:视觉模拟量表;UGI出血:上消化道出血;BW失:体重损失;白细胞:白细胞计数;AST:天冬氨酸氨基转移酶; Cr: creatinine; NIPS: neoadjuvant intraperitoneal and systemic chemotherapy; CRS + HIPEC: cytoreductive surgery + hyperthermic intraperitoneal chemotherapy; C/T: chemotherapy; Hgb: hemoglobin; < 0.05。